Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. - Wikidata - wikimedia - TriplyDB

Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.

Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q42277166

about

NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus Mechanisms of Borrelia burgdorferi internalization and intracellular innate immune signaling The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection.Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.The adaptor molecule CARD9 is essential for tuberculosis control.Beyond macrophages: the diversity of mononuclear cells in tuberculosis.Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1/11-independent IL-1β and IL-18 secretion but not to pyroptosis.The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections IL-17 and Th17 cells in tuberculosis NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila.The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23 Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages.NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9 NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation Macrophages in tuberculosis: friend or foe.NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.In situ IL-12/23p40 production during mycobacterial infection is sustained by CD11bhigh dendritic cells localized in tissue sites distinct from those harboring bacilli.The innate immune response in leprosy.For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection.Innate immune recognition of Mycobacterium tuberculosis Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing.Recognition of bacterial infection by innate immune sensors.NOD2 signaling and role in pathogenic mycobacterium recognition, infection and immunity.The role of innate immune signals in immunity to Brucella abortus.Crohn's as an immune deficiency: from apparent paradox to evolving paradigm.The granuloma in tuberculosis: dynamics of a host-pathogen collusion.Receptor-mediated recognition of mycobacterial pathogens.T regulatory cells: Achilles' heel of Mycobacterium tuberculosis infection?Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.Inflammasome Activation and Function During Infection with Mycobacterium Tuberculosis.Molecular basis of mycobacterial survival in macrophages.Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.

P2860

Q24305119-9AC9256D-9C71-48E9-A9EA-BCBC7579B735 Q26863593-379D9672-FEB0-4BF6-9C43-AD2AEC77C2BF Q26997007-99DBEB00-4855-497C-95D5-23D20B18C30D Q28085251-BDAFA665-A207-4791-96E5-B615C48065EC Q28087160-A5DC4766-39D2-4F53-99C0-E342A81BDF37 Q33429029-63E2B679-3C4B-4E01-9645-7F2B1808F969 Q33785762-AB19468A-6F3D-4124-A5EF-D91BB699732F Q33794955-502DC9D0-BDF0-40BF-A0A3-0F154EE32238 Q34372502-1665CD14-1F29-450E-A703-07A3D92B97F5 Q34387492-A6F8E523-4D0B-4BD7-8EE0-AE4ECF4E0389 Q34512666-1D173ADD-9C8D-4912-B3D5-3306763EA172 Q34545889-07CFDF2F-526E-4035-BE52-525A725A77E3 Q34714303-A8765A15-2B31-47B4-B168-8D4E5DB6F637 Q34785244-BB714E92-FAAE-44C3-B486-A58BA01F530B Q35627704-97AB5B7E-DFF1-4FD6-A3D6-CE3D061952DF Q36156045-7C8165EC-CC32-444E-B0C2-810B2CC933FF Q36283700-E64C918D-E42C-4E3A-A2AA-9854154F3751 Q36689438-6F69F9DF-11B1-49CC-A2E0-FD0DDEFE3FF6 Q36699741-3CACE919-A6D6-4E00-8C7F-B4443EF025C2 Q37147624-4113166E-C40C-4898-90F7-F53E51EF78B5 Q37172148-35DF3341-5E5F-4949-BB11-3730D62D776F Q37199844-DFFEE86F-2AB8-4A49-BA35-EC93BEE4E7C2 Q37292790-7D47863D-9E35-4A75-8804-B98F6FF8EDA1 Q37452964-E9DCDDEB-7388-4B54-B94E-256CECC77671 Q37671102-7B40AE5D-2763-4C46-B47E-2C7DE31B919E Q37846876-4E762B8D-481A-493E-B854-3F7519225DC2 Q37878291-CFCEFA29-506E-43BB-B07B-F979221DD36F Q37891772-1FE53C88-9D35-47AB-B313-A2670C75C5E7 Q38031226-4C8D2977-0A9D-4FEB-A32E-55975F0D11EA Q38032312-6567B9C0-DE21-4D8F-AB9E-91AFAE738232 Q38044173-5F9B0866-3EFF-476A-9C8B-9911BB28C7CE Q38056731-E1558E00-843D-43E9-ADF7-3BE8D0856E19 Q38068957-E656C7BF-2B34-480B-8038-658D0CB6ED72 Q38073249-4BCC743E-837A-4AB2-B85E-D3C7EE5FB942 Q38116540-CC0C8E20-2225-4A47-BCAB-EEFE6D715AEA Q38463142-ED381C9A-CC4F-4B1A-9016-6797093AB716 Q38613635-2112C572-FF80-43E3-B6B3-9AD5F61C4317 Q38909289-0C44D067-90BD-4FDE-9B16-9D1CA7182687 Q39014492-035A80EE-03B7-48C4-892D-EACB757FDC2A Q39070506-2EB90EC8-EB4D-419E-B27F-19A65C4CD370

P2860

Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.

http://www.wikidata.org/entity/Q42277166

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@en

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@nl

type

label

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@en

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@nl

prefLabel

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@en

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@nl

P1433

Q42277166-20ACE3A9-6CCB-46E6-8460-7DCF087903F1

P1476

Q42277166-0B9D4B57-A5D0-464B-A5E2-36C0814FE2E0

P2093

Q42277166-190C94C5-BE5B-4416-A52D-BE9CB9CBF616

Q42277166-24AD3610-DB1E-4F81-AAC1-ECEB65A6D86C

Q42277166-2D51E03E-06A7-4BE3-B98D-58594E5DA248

Q42277166-BCF12F60-12A2-4533-A2E9-603EF85E7EE0

Q42277166-E1A8A338-9608-48A8-BEE1-01B86601E980

P2860

Q42277166-01815C93-8ED2-425F-B522-5C0F69293BCE

Q42277166-061437AA-C714-4E21-9D32-003D53CD962A

Q42277166-0836CAFA-911B-4C10-8CB8-CFA5FE060374

Q42277166-084FED20-133B-4AE5-B72D-B48468412487

Q42277166-14996085-44C9-4449-A880-CE2D79234A50

Q42277166-1CCE3DDF-B718-4401-9709-7970DF13BA01

Q42277166-21DC8B0E-AC9D-4BA0-B26C-2A47F41BDF63

Q42277166-3C31FDD8-0201-44D4-BA36-D5A7EF2B48EB

Q42277166-3C8F4108-C717-4E04-AB84-646D530D7C7B

Q42277166-3EB2F771-5750-4389-931F-0FB4ABC4114E

P304

Q42277166-78701431-8669-4DB8-893B-57C2BA6B3B0E

P31

Q42277166-9207DF7F-5C72-4EF0-B2C4-6B046CB1D447

P356

Q42277166-6DE23CF5-07DB-4358-BBD0-DED8631CE6F4

P407

Q42277166-858B4632-978D-4595-BEC6-3F08F95348E0

P433

Q42277166-2BE654F9-917F-44B8-B55F-7E887C08D239

P478

Q42277166-09C2900F-B711-42F6-A038-4040D892933F

P577

Q42277166-5896DE8E-7A05-4665-95D3-390F8C4135A5

P5875

Q42277166-43CF2A17-91E1-4820-A7B9-003206B2989D

P698

Q42277166-A41A6B7E-A494-4C5A-8E49-80FDCB76EDC8

P921

Q42277166-89C7983E-FB78-47C3-82C6-9E329CB4B7A5

P932

Q42277166-97765AEE-3388-4081-8C9B-119B46E5E925

P356

P1433

Infection and Immunity

P1476

Nucleotide-binding oligomeriza ...... th Mycobacterium tuberculosis.

@en

P2093

Padmini Salgame

http://www.w3.org/2001/XMLSchema#string

Peter J Murray

http://www.w3.org/2001/XMLSchema#string

Sabine Ehrt

http://www.w3.org/2001/XMLSchema#string

Sheetal Gandotra

http://www.w3.org/2001/XMLSchema#string

Sihyug Jang

http://www.w3.org/2001/XMLSchema#string

P2860

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

Induction of direct antimicrobial activity through mammalian toll-like receptors

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

Cryopyrin activates the inflammasome in response to toxins and ATP

P304

5127-5134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00458-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6131359

http://www.w3.org/2001/XMLSchema#string

P698

17709422

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

2168277

http://www.w3.org/2001/XMLSchema#string